Cargando…
Programmed Death Ligand-1 (PD-L1) Is an Independent Negative Prognosticator in Western-World Gallbladder Cancer
SIMPLE SUMMARY: Gallbladder cancer (GBC) is an aggressive malignancy with poor prognosis. Currently, therapeutic options are mostly limited to palliative chemotherapy. Considering the advances of immunotherapy, we assessed the expression of the programmed cell death ligand-1 (PD-L1) as the most wide...
Autores principales: | Albrecht, Thomas, Brinkmann, Fritz, Albrecht, Michael, Lonsdorf, Anke S., Mehrabi, Arianeb, Hoffmann, Katrin, Kulu, Yakup, Charbel, Alphonse, Vogel, Monika N., Rupp, Christian, Köhler, Bruno, Springfeld, Christoph, Schirmacher, Peter, Roessler, Stephanie, Goeppert, Benjamin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038183/ https://www.ncbi.nlm.nih.gov/pubmed/33918309 http://dx.doi.org/10.3390/cancers13071682 |
Ejemplares similares
-
Spatiotemporal analysis of tumour-infiltrating immune cells in biliary carcinogenesis
por: Charbel, Alphonse, et al.
Publicado: (2022) -
The Transmembrane Receptor TIRC7 Identifies a Distinct Subset of Immune Cells with Prognostic Implications in Cholangiocarcinoma
por: Albrecht, Thomas, et al.
Publicado: (2021) -
Low frequency of mismatch repair deficiency in gallbladder cancer
por: Goeppert, Benjamin, et al.
Publicado: (2019) -
STAT1 and STAT3 Exhibit a Crosstalk and Are Associated with Increased Inflammation in Hepatocellular Carcinoma
por: Ploeger, Carolin, et al.
Publicado: (2022) -
Programmed cell death ligand 1 (PD-L1, CD274) in cholangiocarcinoma – correlation with clinicopathological data and comparison of antibodies
por: Kriegsmann, Mark, et al.
Publicado: (2019)